ALNYLAM PHARMACEUTICALS INC
ALNY·02043Q107·US·Common Stock·Healthcare - Biotechnology-13D/G
ALNY (ALNYLAM PHARMACEUTICALS INC) is held by 295 institutional investors as of Q2 2026. Largest holders: FMR LLC ($4.5B), Capital World Investors ($3.4B), BlackRock, Inc. ($3.3B). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 153 funds bought ALNY.
295
Holders
(19 Elite)
$36.9B
Total Value
51% (299)
Consensus
153 buying - 146 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 15, 2026 · Insiders Oct 6, 2026 · Activists May 14, 2026 · Congress Sep 9, 2026
InsiderSBSUPRAN BRYANSell $399KOct 2, 2026
InsiderGYGreenstreet YvonneVest 107 shSep 19, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 304
1 / 16
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer